Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.

OTCQB:EMHTF - Post Discussion

Emerald Health Therapeutics Inc > Time to start averaging down again ???
View:
Post by bligicka on Aug 13, 2021 8:30am

Time to start averaging down again ???

Or shall l wait for a dime ???
Comment by BarstoolSage on Aug 19, 2021 9:50am
General rule is to never average down junior specs...set a sell point and move on. Typically juniors will go up then come back down and they will languish.  This had its run about 3 years ago...and has been falling since Not saying this can't run again...but the field now is pretty crowded and there are better players out there. Having said this...you can totally ignore me if you like. ...more  
Comment by bligicka on Aug 19, 2021 8:37pm
Too late to sell ......only logical thing to do is average down ....waiting for the right price after Chairman of the board was arrested for securities fraud ......
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities